|Institutional Source||Beutler Lab|
|Gene Name||cadherin 20|
|Is this an essential gene?||Possibly non essential (E-score: 0.290)|
|Stock #||R6911 (G1)|
|Chromosomal Location||104768529-104995481 bp(+) (GRCm38)|
|Type of Mutation||missense|
|DNA Base Change (assembly)||T to C at 104984686 bp|
|Amino Acid Change||Isoleucine to Threonine at position 555 (I555T)|
|Ref Sequence||ENSEMBL: ENSMUSP00000052078 (fasta)|
|Gene Model||predicted gene model for transcript(s): [ENSMUST00000062528]|
|Predicted Effect||possibly damaging
AA Change: I555T
PolyPhen 2 Score 0.953 (Sensitivity: 0.79; Specificity: 0.95)
AA Change: I555T
|Coding Region Coverage||
|Validation Efficiency||98% (60/61)|
|MGI Phenotype||FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene is a type II classical cadherin from the cadherin superfamily and one of three cadherin 7-like genes located in a cluster on chromosome 18. The encoded membrane protein is a calcium dependent cell-cell adhesion glycoprotein comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. Type II (atypical) cadherins are defined based on their lack of a HAV cell adhesion recognition sequence specific to type I cadherins. Since disturbance of intracellular adhesion is a prerequisite for invasion and metastasis of tumor cells, cadherins are considered prime candidates for tumor suppressor genes. [provided by RefSeq, Jul 2008]|
|Allele List at MGI|
|Other mutations in this stock||
|Other mutations in Cdh20||
(F):5'- CCTAAGTGCTGAGCCAAACC -3'
(R):5'- TCACCTAAGAGGACAAAGATGC -3'
(F):5'- CAATAGACATGGCTGCGGC -3'
(R):5'- ACTCAAGCTGACTGGGAGC -3'